| ￥1200 | |
| A02896-50 | |
|
|
|
|
|
|
|
|
|
| Specificity | This product is specific to Cytokeratin 17 |
| Host Species | Rabbit |
| Immunogen | A synthesized peptide derived from human Cytokeratin 17 |
| Species Reactivity | Human; Mouse; Rat |
| Conjugate | Unconjugated |
| Working concentrations for specific applications should be determined by the investigators. The appropriate concentrations may be affected by secondary antibody affinity, antigen concentration, the sensitivity of the method of detection, temperature, the length of the incubations, and other factors. The suitability of this antibody for applications other than those listed below has not been determined. The following concentration ranges are recommended starting points for this product. | |||||||||||||
|
|||||||||||||
| Form | Liquid |
| Storage Buffer | Supplied in 10mM phosphate buffered saline , pH 7.4, 150mM sodium chloride, 0.05% BSA, 0.02% sodium azide and 50% glycerol. |
| Storage Instructions | Store at -20°C. This product is stable for 1 year upon receipt, when handled and stored as instructed. |
| Purification | Affinity-chromatography |
| Isotype | Rabbit IgG |
| Clonality | Monoclonal |
Western blot analysis of Cytokeratin 17 expression in HACAT cell lysate. »
| Target Background | Type I keratin involved in the formation and maintenance of various skin appendages, specifically in determining shape and orientation of hair.Required for the correct growth of hair follicles, in particular for the persistence of the anagen (growth) state. |
| Synonyms | 39.1; CK-17; Cytokeratin-17; K17; K1C17; keratin 17; Keratin, type I cytoskeletal 17; Keratin-17; KRT17; PC; PC2; PCHC1; |
For research use only. Not intended for human or animal clinical trials, therapeutic or diagnostic use.
